The importance of IP to a private capital portfolio cannot be overstated particularly for PE investing in IP heavy sectors such as technology, healthcare, pharma and consumer. These intangible assets are of even more importance in uncertain economic times. For a lot of businesses in these sectors IP will be a significant driver of long-term value. In our next HSF PE Thursday session we will be focussing on different aspects of IP – diligence, enforcement, infringement, etc. We hope you will find this helpful in leveraging value from the IP portfolios of your portfolio companies and also in valuing IP when making investments. The session will be led by our specialist non-contentious IP team.
Speakers:
Nicola Yeomans, Partner
Harry Evans, Senior Counsel
Indraneil Ghosh, Senior Associate
